Skip to content

CapEx at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$20.92M+24.8%
UroGen Pharma logo
UroGen PharmaURGN
$54K+22.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K
Nuvation Bio logo
Nuvation BioNUVB
$48K-33.3%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$23K-73.3%
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Operating income-$42.0M-31.9%
Net income-$39.3M-39.6%
EPS (diluted)-$0.64-36.2%

Balance sheet

See full
Cash & equivalents$85.0M-15.7%
Total debt$5.7M-6.9%
Total equity$387.6M+19.8%
Total assets$412.0M+20.0%

Cash flow

See full
Operating cash flow-$32.6M-27.9%
Free cash flow-$32.7M-28.2%

Valuation

See full
Market cap$1.79B+318%
Enterprise value$1.71B+397%

Returns & leverage

See full
Return on equity-36.9%+21.1pp
Debt / equity0.0×
Current ratio20.5×-2.3×

Where this comes from

Reported directly by Tyra Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tyra Biosciences, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tyra Biosciences, Inc.'s capex?
Tyra Biosciences, Inc. (TYRA) reported capex of $88K in Q1 2026.
How has Tyra Biosciences, Inc.'s capex changed year-over-year?
Tyra Biosciences, Inc.'s capex increased by 528.6% year-over-year, from $14K to $88K.
What is the long-term trend for Tyra Biosciences, Inc.'s capex?
Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s capex has grown at a -32.0% compound annual growth rate (CAGR), from $661K to $141K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.